Abstract |
The importance of dermoscopy for diagnosing lentigo maligna melanoma (LMM) is well known. More recently, dermoscopy has been proposed as a useful tool also for the treatment choice and monitoring. Herein, we present an 87-year-old woman, who was successfully treated with imiquimod 5% cream after surgical persistence of residual LMM and for whom dermoscopy was helpful to assist diagnosis and assess tumor persistence after surgery and its response to topical treatment with imiquimod.
|
Authors | Mayara Hamilko de Barros, Claudio Conforti, Roberta Giuffrida, Fernanda Simões Seabra Resende, Nicola Di Meo, Iris Zalaudek |
Journal | Dermatologic therapy
(Dermatol Ther)
Vol. 32
Issue 5
Pg. e13048
(09 2019)
ISSN: 1529-8019 [Electronic] United States |
PMID | 31365164
(Publication Type: Case Reports, Journal Article, Review)
|
Copyright | © 2019 Wiley Periodicals, Inc. |
Chemical References |
- Adjuvants, Immunologic
- Imiquimod
|
Topics |
- Adjuvants, Immunologic
(therapeutic use)
- Administration, Topical
- Aged, 80 and over
- Combined Modality Therapy
- Dermatologic Surgical Procedures
(methods)
- Dermoscopy
(methods)
- Female
- Humans
- Hutchinson's Melanotic Freckle
(diagnosis, pathology, therapy)
- Imiquimod
(therapeutic use)
- Preoperative Care
(methods)
- Prognosis
- Risk Assessment
- Skin Neoplasms
(diagnosis, pathology, therapy)
- Treatment Outcome
|